The use of oral suspension and rationally prescribing alternatives may be supplemental to the implementation of clopidogrel new algorithm comprising CYP2C19 pharmacogenetics and drug interactions
Meng Chen, Quan Zhou Department of Pharmacy, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang Province, People’s Republic of ChinaWe read with great interest the study by Saab et al,1 which shows that all patients who received combination therapy...
Main Authors: | Chen M, Zhou Q |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2016-03-01
|
Series: | Therapeutics and Clinical Risk Management |
Subjects: | |
Online Access: | https://www.dovepress.com/the-use-of-oral-suspension-and-rationally-prescribing-alternatives-may-peer-reviewed-article-TCRM |
Similar Items
-
Pharmacogenetic association study on clopidogrel response in Puerto Rican Hispanics with cardiovascular disease: a novel characterization of a Caribbean population
by: Hernandez-Suarez DF, et al.
Published: (2018-06-01) -
Importance of pharmacogenetics for therapeutic use of clopidogrel
by: Rančić Nemanja, et al.
Published: (2013-01-01) -
A Pharmacogenetic Study of <i>CYP2C19</i> in Acute Coronary Syndrome Patients of Colombian Origin Reveals New Polymorphisms Potentially Related to Clopidogrel Therapy
by: Mariana Angulo-Aguado, et al.
Published: (2021-05-01) -
Pharmacokinetic, pharmacodynamic, and pharmacogenetic assays to monitor clopidogrel therapy
by: Bhawani Yasassri Alvitigala, et al.
Published: (2020-12-01) -
CLOPIDOGREL PHARMACOGENETICS
by: A. N. Meshkov
Published: (2016-01-01)